What A Borderline Faecal Calprotectin Result Means

0
0

If your faecal calprotectin levels are just above the lab’s normal range, that does not by itself mean you have inflammatory bowel disease (IBD). The test detects inflammation in the gut, but it cannot identify the cause. Clinicians interpret the number alongside your symptoms, medicines, recent illness and the pathway used by your local health service.

How Faecal Calprotectin Levels Are Interpreted

Faecal calprotectin is measured in micrograms per gram of stool (µg/g), numerically equivalent to milligrams per kilogram. Many laboratories use about 50 µg/g as the upper limit of normal, but a result above that is not automatically a diagnosis or a referral decision. Some primary-care pathways use under 100 µg/g as a level at which IBD is less likely, 100–250 µg/g as an intermediate range, and above 250 µg/g as a result that may prompt faster specialist assessment.

Those figures are examples, not universal cutoffs. UK pathways themselves differ: one recommends repeating a result of 100–250 µg/g within four weeks, while another advises about six weeks. Laboratories may also use different assays, and results from different methods are not always directly comparable. Check the reference range and advice on your own report, and ask your clinician how your result fits the local pathway.

A low result can make IBD less likely in someone with suitable symptoms, but it does not explain every cause of bowel symptoms. A raised result can occur with IBD, but also with infections and other conditions. The test alone neither confirms nor rules out every diagnosis.

Infections And Medicines Can Affect A Result

Gut infections can temporarily raise calprotectin. Other possible causes include diverticulitis and coeliac disease. Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or naproxen, can also raise the result; some clinical pathways list proton pump inhibitors (PPIs) as a possible influence too.

Tell your clinician about recent diarrhoea or a diagnosed infection, and list medicines you take, including non-prescription painkillers. Pathways differ on what to do about NSAIDs before a repeat: some advise reviewing or avoiding them, while another takes a pragmatic approach and may repeat the test without delaying care. Don’t stop a prescribed medicine on your own. Your clinician can weigh whether a medicine change, infection testing or a repeat sample makes sense in your situation.

When A Repeat Test May Help

If you feel well enough and there are no warning signs requiring investigation, a clinician may suggest repeating a mildly raised result after a short interval. The aim is to see whether the level falls once a temporary infection or other influence has passed, or remains raised and needs further assessment. Some UK pathways use a repeat interval of roughly four to six weeks, but timing depends on local guidance and your clinical picture.

In a 2014 retrospective study, J.P. Seenan and colleagues examined records for 161 people aged 16–50 with new lower-gut symptoms and results of 100–200 µg/g. People with alarm symptoms, positive stool cultures, IBD or NSAID use were excluded. Four people (2.5%) were ultimately diagnosed with IBD during follow-up. This selected group cannot tell you your individual likelihood, and its findings should not be used to dismiss persistent symptoms. It does illustrate why a mildly raised result is often interpreted in context rather than treated as an IBD diagnosis.

If you do repeat the test, ask whether the same laboratory method can be used; different assays can produce results that are difficult to compare. Follow the sample-collection and storage instructions supplied by your laboratory.

Symptoms That Should Not Wait For A Repeat

Do not rely on a repeat calprotectin test instead of assessment if you have rectal bleeding, unexplained weight loss, anaemia, a persistent change in bowel habits, night-time diarrhoea or a lump or mass. A significant family history of bowel cancer may also change the investigation plan. Calprotectin is not a bowel-cancer screening test and cannot rule cancer out; clinicians use other assessments when cancer is a concern.

Seek prompt medical assessment for bloody diarrhoea with feeling seriously unwell or worsening symptoms. If symptoms are significant or getting worse, contact a clinician rather than waiting for a repeat result. They can decide whether you need tests or referral based on your whole history. If you are worried about your result, ask the clinician who ordered it to explain the lab’s range, the next step and how soon to follow up.